Isomorphic Labs signs AI drug discovery deals with Novartis, Lilly

Jan 10, 2024 · Alphabet subsidiary Isomorphic Labs has signed drug discovery collaborations potentially worth nearly $3 billion with Eli Lilly and Novartis. In the first deal, Isomorphic Labs …

CouponFollow Extension

$3
OFF

Isomorphic Labs Signs AI Drug Discovery Deals With Novartis, Lilly

4 weeks from now

Jan 10, 2024 · Alphabet subsidiary Isomorphic Labs has signed drug discovery collaborations potentially worth nearly $3 billion with Eli Lilly and Novartis. In the first deal, Isomorphic Labs …

pharmamanufacturing.com

$3
OFF

Isomorphic Signs $3B In AI Drug Discovery Pacts With Lilly, Novartis

4 weeks from now

Jan 7, 2024 · Alphabet's artificial intelligence (AI) start-up Isomorphic Labs has nabbed a pair of drug discovery deals with Eli Lilly and Novartis worth close to $3 billion. The announcement …

firstwordhealthtech.com

$3
OFF

DeepMind’s Isomorphic Inks $3B Worth Of Deals With Lilly And …

4 weeks from now

Jan 8, 2024 · With its first big deals since its launch about two years ago, AI spinout Isomorphic yesterday announced two agreements worth $3B worth with each Eli Lilly and Novartis to …

insideprecisionmedicine.com

$3
OFF

DeepMind Spin-off Aims To Halve Drug Discovery Times Following …

4 weeks from now

Jan 10, 2024 · Chief of Google’s AI unit and Isomorphic Labs spells out targets following $3bn Eli Lilly-Novartis partnerships. ... Interest in using AI in drug discovery is soaring, with companies …

ft.com

FAQs about Isomorphic Labs signs AI drug discovery deals with Novartis, Lilly Coupon?

What is isomorphic labs doing with Eli Lilly & Novartis?

Isomorphic Labs, a unit of Google-parent Alphabet, announced strategic research collaborations with Eli Lilly and Novartis. The partnerships with Eli Lilly and Novartis will focus on small-molecule treatments and multiple targets. ...

Does isomorphic Labs work with Novartis?

Isomorphic Labs, a subsidiary of Alphabet Inc., on Monday said it entered into strategic research collaboration agreements with Novartis AG and Eli Lilly & Co. Bloomberg—Isomorphic Labs, a subsidiary of Alphabet Inc., said it entered into strategic research collaboration agreements with Novartis AG and Eli Lilly & Co. ...

What is the Novartis-isomorphic collaboration?

The collaboration between Novartis and Isomorphic Labs will focus on finding small molecule therapeutics vs. three targets. Alphabet's Isomorphic receives $37.5 million cash initially, with Novartis covering some research costs. Isomorphic is also eligible for up to $1.2 billion in milestone payments, plus possible royalties. ...

How much is isomorphic labs worth?

Isomorphic Labs, the London-based, drug discovery–focused spinout of Google AI R&D division DeepMind, today announced that it’s entered into strategic partnerships with two pharmaceutical giants, Eli Lilly and Novartis, to apply AI to discover new medications to treat diseases. The deals have a combined value of around $3 billion. ...

Will isomorphic labs partner with Lilly?

This marks Isomorphic Labs' first pharmaceutical partnership. Under the terms of the agreement, Isomorphic Labs will partner with Lilly to discover small molecule therapeutics against multiple targets and will receive an upfront cash payment of $45 million. ...

Who is isomorphic labs?

Alphabet’s artificial intelligence start-up Isomorphic Labs has made a splash at the start of the JP Morgan Healthcare conference this week, announcing its first pharma partnerships with Eli Lilly and Novartis, worth almost $3 billion. ...